Patents Represented by Attorney Larry W. Stults, Ph.D.
  • Patent number: 6006470
    Abstract: The use of mannose binding lectins derived from Amaryllidaceae, Alliaceae, or Vicieae for the control of nematodes, in which said use may be either direct or via transgenic plant expression, and a method therefor.
    Type: Grant
    Filed: September 30, 1996
    Date of Patent: December 28, 1999
    Assignee: Novartis AG
    Inventors: Irene Geoghegan, Walter Robertson, Nicholas Birch, Angharad Margaret Roscoe Gatehouse
  • Patent number: 5858745
    Abstract: Particularly effective B.t. insecticides are obtained by culturing to the sporulation stage novel transformant obtained on transforming B.t. kurstaki H.D. 562 with DNA expressing in the B.t. certain mutant endotoxin genes. Such transformants and other B.t. transformants generally may be obtained in high transformation frequencies by the electrotransformation of B.t. cells while in a hypertonic state followed by maintaining the cells in a hypertonic medium for a time sufficient to obtain intact cells. Transformation of B.t. tenebroinis and B.t. aizawai is also described.
    Type: Grant
    Filed: October 24, 1997
    Date of Patent: January 12, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Cindy Lou Jellis, Noah D. Beerman, Jean-Christophe Piot
  • Patent number: 5756683
    Abstract: The present invention relates to monoclonal antibodies that are distinguished by a high degree of selectivity and affinity towards herbicides from the group of the sulfonylureas, especially towards sulfonylurea herbicides of formula (A) ##STR1## wherein X is a mono- or di-substituted 6-membered heterocycle having from one to three nitrogen atoms and bonded via carbon, but is preferably mono- or di-substituted s-triazine or pyrimidine; andn is an integer from 0 to 4, preferably the number 1, and that are therefore outstandingly suitable for use in an immunoassay for the rapid and effective detection of the said sulfonylurea herbicides in soil, water or air samples or in plant extracts, and to methods for the production of said monoclonal antibodies. The present invention relates also to hybridoma cell lines that produce said monoclonal antibodies and to immunological detection methods using said monoclonal antibodies, and to test kits that may be used in those detection methods.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: May 26, 1998
    Assignee: Novartis Finance Corporation
    Inventors: Jean-Marc Schlaeppi, Dietmar Huglin